China’s AI Drug Companies Secure Multibillion-Dollar Big Pharma Partnerships
Western drug makers are increasingly looking to Chinese biotechnology companies specializing in artificial intelligence to discover new medicines. A number of new multi-billion-dollar deals are a testament to China’s emerging status as a hub for cutting-edge medicines. In June, AstraZeneca paid more... Read More